1. Kaufmann M, Blohmer JU, Eiermann W et al. (2005) International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer. Update of Recommendations 2004. (In prep.)
2. http://www.ago-online.org
3. http://www.germanbreastgroup.de
4. Kuerer HM, Newman LA, Smith TL et al. (1999) Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17: 460–469
5. Hurley J, Hurley, Doliny P et al. (2002) Neoadjuvant herceptin/taxotere/cisplatin in the treatment of locally advanced and inflammatory breast cancer. Proc ASCO 20: Abstract 196